749 related articles for article (PubMed ID: 25084174)
1. Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.
Benveniste EN; Liu Y; McFarland BC; Qin H
J Interferon Cytokine Res; 2014 Aug; 34(8):577-88. PubMed ID: 25084174
[TBL] [Abstract][Full Text] [Related]
2. Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.
Liu Y; Gibson SA; Benveniste EN; Qin H
Crit Rev Immunol; 2015; 35(6):505-27. PubMed ID: 27279046
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
Liu Y; Holdbrooks AT; De Sarno P; Rowse AL; Yanagisawa LL; McFarland BC; Harrington LE; Raman C; Sabbaj S; Benveniste EN; Qin H
J Immunol; 2014 Jan; 192(1):59-72. PubMed ID: 24323580
[TBL] [Abstract][Full Text] [Related]
4. Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway.
Dang C; Lu Y; Chen X; Li Q
Front Immunol; 2021; 12():650708. PubMed ID: 33927721
[TBL] [Abstract][Full Text] [Related]
5. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.
Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ
Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236
[TBL] [Abstract][Full Text] [Related]
6. Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases.
Yan Z; Gibson SA; Buckley JA; Qin H; Benveniste EN
Clin Immunol; 2018 Apr; 189():4-13. PubMed ID: 27713030
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes.
Natarajan C; Bright JJ
J Immunol; 2002 Jun; 168(12):6506-13. PubMed ID: 12055272
[TBL] [Abstract][Full Text] [Related]
8. Connection between JAK/STAT and PPARγ Signaling During the Progression of Multiple Sclerosis: Insights into the Modulation of T-Cells and Immune Responses in the Brain.
Kumar N; Sharma N; Mehan S
Curr Mol Pharmacol; 2021; 14(5):823-837. PubMed ID: 33645493
[TBL] [Abstract][Full Text] [Related]
9. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.
You Z; Timilshina M; Jeong BS; Chang JH
Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958
[TBL] [Abstract][Full Text] [Related]
10. Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.
Yin L; Chen Y; Qu Z; Zhang L; Wang Q; Zhang Q; Li L
J Neuroimmunol; 2014 Sep; 274(1-2):28-37. PubMed ID: 25012120
[TBL] [Abstract][Full Text] [Related]
11. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Coskun M; Salem M; Pedersen J; Nielsen OH
Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
[TBL] [Abstract][Full Text] [Related]
12. The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Xin P; Xu X; Deng C; Liu S; Wang Y; Zhou X; Ma H; Wei D; Sun S
Int Immunopharmacol; 2020 Mar; 80():106210. PubMed ID: 31972425
[TBL] [Abstract][Full Text] [Related]
13. Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.
Wang L; Hu Y; Song B; Xiong Y; Wang J; Chen D
Inflamm Res; 2021 Jul; 70(7):753-764. PubMed ID: 34212215
[TBL] [Abstract][Full Text] [Related]
14. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.
Zhao R; Hu Z; Zhang X; Huang S; Yu G; Wu Z; Yu W; Lu J; Ruan B
Cell Commun Signal; 2024 Jan; 22(1):68. PubMed ID: 38273295
[TBL] [Abstract][Full Text] [Related]
15. JAK inhibition and progressive kidney disease.
Brosius FC; He JC
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):88-95. PubMed ID: 25415616
[TBL] [Abstract][Full Text] [Related]
16. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.
Xue C; Yao Q; Gu X; Shi Q; Yuan X; Chu Q; Bao Z; Lu J; Li L
Signal Transduct Target Ther; 2023 May; 8(1):204. PubMed ID: 37208335
[TBL] [Abstract][Full Text] [Related]
17. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
Tzeng HT; Chyuan IT; Lai JH
Biochem Pharmacol; 2021 Nov; 193():114760. PubMed ID: 34492272
[TBL] [Abstract][Full Text] [Related]
18. COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis.
Muthian G; Raikwar HP; Johnson C; Rajasingh J; Kalgutkar A; Marnett LJ; Bright JJ
J Clin Immunol; 2006 Jan; 26(1):73-85. PubMed ID: 16418805
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-κB signaling pathways.
Jia Y; Jing J; Bai Y; Li Z; Liu L; Luo J; Liu M; Chen H
PLoS One; 2011; 6(10):e27006. PubMed ID: 22066025
[TBL] [Abstract][Full Text] [Related]
20. Molecular dissection of Janus kinases as drug targets for inflammatory diseases.
Kwon S
Front Immunol; 2022; 13():1075192. PubMed ID: 36569926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
